{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:25:23Z","timestamp":1787023523554,"version":"build-2736575974"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"The Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ymeth.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T23:36:59Z","timestamp":1781566619000},"page":"29-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons"],"prefix":"10.1016","volume":"254","author":[{"given":"Chanshuai","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Nguyen-Renou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Benaliouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol X-Q.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeshah","family":"Alluli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Villegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore K.","family":"Beitel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shlaifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang E.","family":"Reintsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea I.","family":"Krahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Del","family":"Cid Pellitero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Fon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Durcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2026.06.005_b0005","doi-asserted-by":"crossref","unstructured":"J. Burr\u00e9, M. Sharma, T. Tsetsenis, V. Buchman, M.R. Etherton, T.C. S\u00fcdhof, Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro, Science (New York, N.Y.) 329(5999) (2010) 1663-7.DOI: 10.1126\/science.1195227.","DOI":"10.1126\/science.1195227"},{"issue":"7","key":"10.1016\/j.ymeth.2026.06.005_b0010","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.ymeth.2026.06.005_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102113","article-title":"Visualization of alpha-synuclein trafficking via nanogold labeling and electron microscopy","volume":"4","author":"Bayati","year":"2023","journal-title":"STAR Protoc."},{"key":"10.1016\/j.ymeth.2026.06.005_b0020","series-title":"Proceedings of the National Academy of Sciences of the United States of America 117(9)","first-page":"4971","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","author":"Mahul-Mellier","year":"2020"},{"issue":"2","key":"10.1016\/j.ymeth.2026.06.005_b0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ymeth.2026.06.005_b0030","doi-asserted-by":"crossref","unstructured":"S. Zhang, R. Zhu, B. Pan, H. Xu, M.F. Olufemi, R.J. Gathagan, Y. Li, L. Zhang, J. Zhang, W. Xiang, E.M. Kagan, X. Cao, C. Yuan, S.J. Kim, C.K. Williams, S. Magaki, H.V. Vinters, H.A. Lashuel, B.A. Garcia, E. James Petersson, J.Q. Trojanowski, V.M. Lee, C. Peng, Post-translational modifications of soluble alpha-synuclein regulate the amplification of pathological alpha-synuclein, Nat Neurosci 26(2) (2023) 213-225.DOI: 10.1038\/s41593-022-01239-7.","DOI":"10.1038\/s41593-022-01239-7"},{"issue":"1\u20132","key":"10.1016\/j.ymeth.2026.06.005_b0035","first-page":"33","article-title":"Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells","volume":"866","author":"Zhou","year":"2000","journal-title":"Brain Res."},{"issue":"16","key":"10.1016\/j.ymeth.2026.06.005_b0040","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.20-16-06048.2000","article-title":"The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity","volume":"20","author":"Ostrerova-Golts","year":"2000","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.ymeth.2026.06.005_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111102","article-title":"Rapid macropinocytic transfer of alpha-synuclein to lysosomes","volume":"40","author":"Bayati","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymeth.2026.06.005_b0050","doi-asserted-by":"crossref","unstructured":"A. Bayati, R. Ayoubi, A. Aguila, C.E. Zorca, G. Deyab, C. Han, S.J. Recinto, E. Nguyen-Renou, C. Rocha, G. Maussion, W. Luo, I. Shlaifer, E. Banks, I. McDowell, E. Del Cid Pellitero, X.E. Ding, B. Sharif, P. Seguela, M. Yaqubi, C.X. Chen, Z. You, N. Abdian, H.M. McBride, E.A. Fon, J.A. Stratton, T.M. Durcan, P.C. Nahirney, P.S. McPherson, Modeling Parkinson's disease pathology in human dopaminergic neurons by sequential exposure to alpha-synuclein fibrils and proinflammatory cytokines, Nat Neurosci 27(12) (2024) 2401-2416.DOI: 10.1038\/s41593-024-01775-4.","DOI":"10.1038\/s41593-024-01775-4"},{"issue":"1","key":"10.1016\/j.ymeth.2026.06.005_b0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.ymeth.2026.06.005_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1049418","article-title":"Time-dependent alterations in the rat nigrostriatal system after intrastriatal injection of fibrils formed by \u03b1-Syn and tau fragments","volume":"14","author":"Yang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ymeth.2026.06.005_b0065","doi-asserted-by":"crossref","unstructured":"K.C. Luk, V. Kehm, J. Carroll, B. Zhang, P. O'Brien, J.Q. Trojanowski, V.M. Lee, Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice, Science (New York, N.Y.) 338(6109) (2012) 949-53.DOI: 10.1126\/science.1227157.","DOI":"10.1126\/science.1227157"},{"issue":"5","key":"10.1016\/j.ymeth.2026.06.005_b0070","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymeth.2026.06.005_b0075","doi-asserted-by":"crossref","unstructured":"M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe, R.L. Nussbaum, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science (New York, N.Y.) 276(5321) (1997) 2045-7.DOI: 10.1126\/science.276.5321.2045.","DOI":"10.1126\/science.276.5321.2045"},{"issue":"6","key":"10.1016\/j.ymeth.2026.06.005_b0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/mds.25499","article-title":"The many faces of alpha-synuclein mutations","volume":"28","author":"Kasten","year":"2013","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.ymeth.2026.06.005_b0085","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymeth.2026.06.005_b0090","doi-asserted-by":"crossref","unstructured":"S. Lesage, M. Anheim, F. Letournel, L. Bousset, A. Honore, N. Rozas, L. Pieri, K. Madiona, A. Durr, R. Melki, C. Verny, A. Brice, G. French Parkinson's Disease Genetics Study, G51D alpha-synuclein mutation causes a novel parkinsonian-pyramidal syndrome, Ann Neurol 73(4) (2013) 459-71.DOI: 10.1002\/ana.23894.","DOI":"10.1002\/ana.23894"},{"issue":"11","key":"10.1016\/j.ymeth.2026.06.005_b0095","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e31828727ba","article-title":"A novel alpha-synuclein missense mutation in Parkinson disease","volume":"80","author":"Proukakis","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.ymeth.2026.06.005_b0100","doi-asserted-by":"crossref","unstructured":"J.J. Zarranz, J. Alegre, J.C. Gomez-Esteban, E. Lezcano, R. Ros, I. Ampuero, L. Vidal, J. Hoenicka, O. Rodriguez, B. Atares, V. Llorens, E. Gomez Tortosa, T. del Ser, D.G. Munoz, J.G. de Yebenes, The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia, Ann Neurol 55(2) (2004) 164-73.DOI: 10.1002\/ana.10795.","DOI":"10.1002\/ana.10795"},{"issue":"9440","key":"10.1016\/j.ymeth.2026.06.005_b0105","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson's disease","volume":"364","author":"Chartier-Harlin","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ymeth.2026.06.005_b0110","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/01.wnl.0000254458.17630.c5","article-title":"Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication","volume":"68","author":"Fuchs","year":"2007","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ymeth.2026.06.005_b0115","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","article-title":"Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication","volume":"62","author":"Miller","year":"2004","journal-title":"Neurology"},{"issue":"5646","key":"10.1016\/j.ymeth.2026.06.005_b0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"Gwinn-Hardy, alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.ymeth.2026.06.005_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab223","article-title":"Midbrain organoids with an SNCA gene triplication model key features of synucleinopathy","volume":"3","author":"Mohamed","year":"2021","journal-title":"Brain communications"},{"key":"10.1016\/j.ymeth.2026.06.005_bib296","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ncomms1453","article-title":"Parkinson\u2019s disease induced pluripotent stem cells with triplication of the \u03b1-synuclein locus","volume":"2","author":"Devine","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymeth.2026.06.005_bib297","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/ejn.14286","article-title":"Engineering synucleinopathy-resistant human dopaminergic neurons by CRISPR-mediated deletion of the SNCA gene","volume":"49","author":"Chen","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ymeth.2026.06.005_b0130","doi-asserted-by":"crossref","unstructured":"C.X. Chen, N. Abdian, G. Maussion, R.A. Thomas, I. Demirova, E. Cai, M. Tabatabaei, L.K. Beitel, J. Karamchandani, E.A. Fon, T.M. Durcan, A Multistep Workflow to Evaluate Newly Generated iPSCs and Their Ability to Generate Different Cell Types, Methods and protocols 4(3) (2021).DOI: 10.3390\/mps4030050.","DOI":"10.3390\/mps4030050"},{"key":"10.1016\/j.ymeth.2026.06.005_b0135","article-title":"Induction of Dopaminergic or Cortical neuronal progenitors from iPSCs","author":"Chen","year":"2019","journal-title":"Zenodo"},{"key":"10.1016\/j.ymeth.2026.06.005_b0140","article-title":"Generation of dopaminergic or cortical neurons from neuronal progenitors","author":"Chen","year":"2019","journal-title":"Zenedo"},{"key":"10.1016\/j.ymeth.2026.06.005_b0145","unstructured":"NeuroEDDU. https:\/\/github.com\/neuroeddu\/Auto-qPCR. 2020)."},{"issue":"1","key":"10.1016\/j.ymeth.2026.06.005_b0150","doi-asserted-by":"crossref","first-page":"21293","DOI":"10.1038\/s41598-021-99727-6","article-title":"Auto-qPCR; a python-based web app for automated and reproducible analysis of qPCR data","volume":"11","author":"Maussion","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ymeth.2026.06.005_b0155","first-page":"345","article-title":"Lewy bodies are ubiquitinated","volume":"75","author":"Kuzuhara","year":"1988","journal-title":"A light and electron microscopic immunocytochemical study, Acta neuropathologica"},{"issue":"12","key":"10.1016\/j.ymeth.2026.06.005_b0160","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/jnen\/62.12.1241","article-title":"Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62","volume":"62","author":"Kuusisto","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"7","key":"10.1016\/j.ymeth.2026.06.005_b0165","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"368","key":"10.1016\/j.ymeth.2026.06.005_b0170","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag2210","article-title":"Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson's disease","volume":"8","author":"Ghosh","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymeth.2026.06.005_b0175","doi-asserted-by":"crossref","unstructured":"S. Mittal, K. Bj\u00f8rnevik, D.S. Im, A. Flierl, X. Dong, J.J. Locascio, K.M. Abo, E. Long, M. Jin, B. Xu, Y.K. Xiang, J.C. Rochet, A. Engeland, P. Rizzu, P. Heutink, T. Bartels, D.J. Selkoe, B.J. Caldarone, M.A. Glicksman, V. Khurana, B. Sch\u00fcle, D.S. Park, T. Riise, C.R. Scherzer, \u03b22-Adrenoreceptor is a regulator of the \u03b1-synuclein gene driving risk of Parkinson's disease, Science (New York, N.Y.) 357(6354) (2017) 891-898.DOI: 10.1126\/science.aaf3934.","DOI":"10.1126\/science.aaf3934"},{"issue":"6","key":"10.1016\/j.ymeth.2026.06.005_b0180","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00401-013-1114-9","article-title":"Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease","volume":"125","author":"Wagner","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ymeth.2026.06.005_b0185","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.biopha.2015.08.025","article-title":"MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting \u03b1-synuclein expression in MPTP-induced Parkinson's disease mouse","volume":"74","author":"Wang","year":"2015","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"16","key":"10.1016\/j.ymeth.2026.06.005_b0190","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202200216","article-title":"Myricetin Inhibits \u03b1-Synuclein Amyloid Aggregation by Delaying the Liquid-to-Solid Phase Transition","volume":"23","author":"Xu","year":"2022","journal-title":"Chembiochem : a European journal of chemical biology"},{"issue":"26","key":"10.1016\/j.ymeth.2026.06.005_b0195","doi-asserted-by":"crossref","first-page":"26846","DOI":"10.1074\/jbc.M403129200","article-title":"The flavonoid baicalein inhibits fibrillation of alpha-synuclein and disaggregates existing fibrils","volume":"279","author":"Zhu","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.ymeth.2026.06.005_b0200","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ymeth.2026.06.005_b0205","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nn1443","article-title":"Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease","volume":"8","author":"Chen","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymeth.2026.06.005_b0210","series-title":"Proceedings of the National Academy of Sciences of the United States of America 105(2)","first-page":"763","article-title":"The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease","author":"Gorbatyuk","year":"2008"},{"issue":"34","key":"10.1016\/j.ymeth.2026.06.005_b0215","doi-asserted-by":"crossref","first-page":"23179","DOI":"10.1074\/jbc.M802223200","article-title":"Serine 129 phosphorylation of alpha-synuclein induces unfolded protein response-mediated cell death","volume":"283","author":"Sugeno","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymeth.2026.06.005_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2025.104023","article-title":"Rethinking Parkinson's: The role of proteostasis networks and autophagy in disease progression","volume":"134","author":"Sharma","year":"2025","journal-title":"Mol. Cell. Neurosci."},{"issue":"12","key":"10.1016\/j.ymeth.2026.06.005_b0225","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1096\/fj.10-179192","article-title":"Phosphorylated \u03b1-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease","volume":"25","author":"Foulds","year":"2011","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.ymeth.2026.06.005_b0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1365-2990.2002.00394.x","article-title":"Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: possible role in tangle formation","volume":"28","author":"Kuusisto","year":"2002","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"11","key":"10.1016\/j.ymeth.2026.06.005_b0235","doi-asserted-by":"crossref","first-page":"20900","DOI":"10.1002\/jcp.28695","article-title":"Polyphenolic flavonoid (Myricetin) upregulated proteasomal degradation mechanisms: Eliminates neurodegenerative proteins aggregation","volume":"234","author":"Joshi","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.ymeth.2026.06.005_b0240","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/jnc.13180","article-title":"Phenolic compounds prevent the oligomerization of \u03b1-synuclein and reduce synaptic toxicity","volume":"134","author":"Takahashi","year":"2015","journal-title":"Journal of neurochemistry"},{"key":"10.1016\/j.ymeth.2026.06.005_b0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bbrc.2021.08.049","article-title":"Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative","volume":"574","author":"Chau","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ymeth.2026.06.005_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.763476","article-title":"Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination - A Preclinical Study in Model Mice","volume":"15","author":"Umeda","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ymeth.2026.06.005_b0255","doi-asserted-by":"crossref","unstructured":"W.E. Reintsch, A.I. Krahn, C. Han, E. Nguyen-Renou, C.X.Q. Chen, W. Luo, I. Shlaifer, T.A. Pfeifer, E.A. Fon, T.M. Durcan, A high-content imaging workflow to screen for molecules that reduce cellular uptake of \u03b1-synuclein preformed fibrils, bioRxiv (2025) 2025.12.22.695981.DOI: 10.64898\/2025.12.22.695981.","DOI":"10.64898\/2025.12.22.695981"},{"issue":"1","key":"10.1016\/j.ymeth.2026.06.005_b0260","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41531-022-00357-0","article-title":"Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies","volume":"8","author":"Magalhaes","year":"2022","journal-title":"NPJ Parkinsons Dis"},{"issue":"1\u20132","key":"10.1016\/j.ymeth.2026.06.005_b0265","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(97)00710-6","article-title":"Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients","volume":"235","author":"Mu\u00f1oz","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"9095","key":"10.1016\/j.ymeth.2026.06.005_b0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(05)78089-2","article-title":"Analysis of the alpha-synuclein G209A mutation in familial Parkinson's disease","volume":"351","author":"Zareparsi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ymeth.2026.06.005_b0275","doi-asserted-by":"crossref","unstructured":"D. Lin, H. Zhang, J. Zhang, K. Huang, Y. Chen, X. Jing, E. Tao, \u03b1-Synuclein Induces Neuroinflammation Injury through the IL6ST-AS\/STAT3\/HIF-1\u03b1 Axis, International journal of molecular sciences 24(2) (2023).DOI: 10.3390\/ijms24021436.","DOI":"10.3390\/ijms24021436"},{"issue":"12","key":"10.1016\/j.ymeth.2026.06.005_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111401","article-title":"Interaction of RAGE with \u03b1-synuclein fibrils mediates inflammatory response of microglia","volume":"40","author":"Long","year":"2022","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.ymeth.2026.06.005_b0285","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12974-021-02158-3","article-title":"Crosstalk between astrocytes and microglia results in increased degradation of \u03b1-synuclein and amyloid-\u03b2 aggregates","volume":"18","author":"Rostami","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"7","key":"10.1016\/j.ymeth.2026.06.005_b0290","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s12035-021-02327-8","article-title":"Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance","volume":"58","author":"Streubel-Gallasch","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymeth.2026.06.005_b0295","doi-asserted-by":"crossref","unstructured":"M.F. Dorion, M. Yaqubi, K. Senkevich, N.W. Kieran, A. MacDonald, C.X.Q. Chen, W. Luo, A. Wallis, I. Shlaifer, J.A. Hall, R.W.R. Dudley, I.A. Glass, L. Birth Defects Research, J.A. Stratton, E.A. Fon, T. Bartels, J.P. Antel, Z. Gan-Or, T.M. Durcan, L.M. Healy, MerTK is a mediator of alpha-synuclein fibril uptake by human microglia, Brain 147(2) (2024) 427-443.DOI: 10.1093\/brain\/awad298.","DOI":"10.1093\/brain\/awad298"}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326001520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:48Z","timestamp":1787021268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326001520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":61,"alternative-id":["S1046202326001520"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.06.005","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An automated workflow for quantifying the formation of synuclein aggregates in human dopaminergic neurons","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}